EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
ramusmedical
Regional News

In major shake-up, Novartis combines pharma, oncology units, leaving cancer commercial head, CMO out of job

Novartis CEO Vas Narasimhan is giving the Swiss pharma a huge makeover even ahead of a possible spinoff of generics unit Sandoz, pushing out three C-level executives ...
4 April 2022 Regional News cancer | makeover
Continue Reading →
Regional News

JPM 2022: Vertex’s Trikafta holds the line as company lays groundwork for gene editing launch

Vertex Pharmaceuticals is well known for its slew of cystic fibrosis medications, and newcomer Trikafta is pulling its weight. Over the course of 2021, the med clinch...
11 January 2022 Regional News company | fibrosis
Continue Reading →
Volume 13 Issue 6

A Guide for Establishing and Governing Data Collection Standards

Many data management teams report that their standards initiatives have stalled or failed because executives aren't bought-in, standards are over-proliferated, or the...
9 December 2021 Volume 13 Issue 6 biotechnology | clinical data
Continue Reading →
Regional News

Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators’ review time only one benefit

Merck & Co.’s $11.5 billion bid for Acceleron Pharma is hitting a delay just as activist investors threaten to derail the deal altogether. Merck has withdrawn it...
2 November 2021 Regional News Acceleron Pharma | clinical research
Continue Reading →
Regional News

Roche’s Polivy to hit $2.4B as doctors expect ‘significant switching’ in newly diagnosed lymphoma: analyst

Roche Pharmaceuticals CEO Bill Anderson recently pegged lymphoma drug Polivy’s potential expansion into newly diagnosed patients as a multibillion-dollar opportunity....
8 September 2021 Regional News Lymphoma | pharmaceuticals
Continue Reading →
Europe

DelMar Pharmaceuticals boosted on positive clinical trials update for VAL-083

Shares in DelMar Pharmaceuticals Inc surged over 10% Tuesday on Nasdaq Shares in DelMar Pharmaceuticals Inc (NASDAQ:DMPI) surged over 10% Tuesday as it gave positiv...
18 April 2018 Europe | North America clinical | DelMar
Continue Reading →
Europe

Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the presentation of clinical data on ARC-520, the company's prior generation investigational medicine fo...
11 April 2018 Europe ARC-520 | arrowhead
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte